{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T12:41:54Z","timestamp":1762864914437},"reference-count":63,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2005,5,1]],"date-time":"2005-05-01T00:00:00Z","timestamp":1114905600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Trends in Molecular Medicine"],"published-print":{"date-parts":[[2005,5]]},"DOI":"10.1016\/j.molmed.2005.03.005","type":"journal-article","created":{"date-parts":[[2005,4,14]],"date-time":"2005-04-14T13:54:58Z","timestamp":1113486898000},"page":"232-239","source":"Crossref","is-referenced-by-count":36,"title":["Therapeutic promise of JNK ATP-noncompetitive inhibitors"],"prefix":"10.1016","volume":"11","author":[{"given":"Marie A.","family":"Bogoyevitch","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.molmed.2005.03.005_bib1","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1126\/science.1075762","article-title":"The protein kinase complement of the human genome","volume":"298","author":"Manning","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.molmed.2005.03.005_bib2","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.2174\/1381612043384420","article-title":"Targeting MAPK signalling: Prometheus' fire or Pandora's box?","volume":"10","author":"Boldt","year":"2004","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.molmed.2005.03.005_bib3","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1038\/nrd1132","article-title":"Targeting JNK for therapeutic benefit: from JUNK to gold","volume":"2","author":"Manning","year":"2003","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.molmed.2005.03.005_bib4","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.bbapap.2003.11.016","article-title":"Targeting the JNK MAPK cascade for inhibition \u2013 basic science and therapeutic potential","volume":"1697","author":"Bogoyevitch","year":"2004","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.molmed.2005.03.005_bib5","doi-asserted-by":"crossref","first-page":"13681","DOI":"10.1073\/pnas.251194298","article-title":"SP600125, and anthrapyrazolone inhibitor of Jun N-terminal kinase","volume":"98","author":"Bennett","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molmed.2005.03.005_bib6","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1042\/bj20021535","article-title":"The specificities of protein kinase inhibitors: an update","volume":"371","author":"Bain","year":"2003","journal-title":"Biochem. J."},{"key":"10.1016\/j.molmed.2005.03.005_bib7","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S1074-5521(03)00159-5","article-title":"The structure of JNK3 in complex with small molecule inhibitors: structural basis for potency and selectivity","volume":"10","author":"Scapin","year":"2003","journal-title":"Chem. Biol."},{"key":"10.1016\/j.molmed.2005.03.005_bib8","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1124\/jpet.103.064246","article-title":"AS601245 [1,3-benzothiazol-2-yl (2-{[2-(3-pyridinyl) ethyl] amino}-4 pyrimidinyl) acetonitrile]: a c-Jun NH2-terminal protein kinase inhibitor with neuroprotective properties","volume":"310","author":"Carboni","year":"2004","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.molmed.2005.03.005_bib9","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1038\/sj.bjp.0705873","article-title":"Inhibition of c-Jun N-terminal kinase decreases cardiomyocyte apoptosis and infarct size after myocardial ischemia and reperfusion in anaesthetized rats","volume":"142","author":"Ferrandi","year":"2004","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.molmed.2005.03.005_bib10","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1126\/science.281.5383.1671","article-title":"A mammalian scaffold complex that selectively mediates MAP kinase activation","volume":"281","author":"Whitmarsh","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.molmed.2005.03.005_bib11","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1126\/science.277.5326.693","article-title":"A cytoplasmic inhibitor of the JNK signal transduction pathway","volume":"277","author":"Dickens","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.molmed.2005.03.005_bib12","doi-asserted-by":"crossref","first-page":"7245","DOI":"10.1128\/MCB.19.10.7245","article-title":"The JIP group of mitogen-activated protein kinase scaffold proteins","volume":"19","author":"Yasuda","year":"1999","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.molmed.2005.03.005_bib13","doi-asserted-by":"crossref","first-page":"3967","DOI":"10.1242\/jcs.114.22.3967","article-title":"The Ste5p scaffold","volume":"114","author":"Elion","year":"2001","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.molmed.2005.03.005_bib14","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1101\/gad.1216504","article-title":"An essential role of the JIP1 scaffold protein for JNK activation in adipose tissue","volume":"18","author":"Jaeschke","year":"2004","journal-title":"Genes Dev."},{"key":"10.1016\/j.molmed.2005.03.005_bib15","doi-asserted-by":"crossref","first-page":"26722","DOI":"10.1074\/jbc.273.41.26722","article-title":"Extracellular signal-regulated protein kinase\/Jun kinase cross-talk underlies endothelial cell growth factor-induced endothelial cell proliferation","volume":"273","author":"Pedram","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2005.03.005_bib16","doi-asserted-by":"crossref","first-page":"8415","DOI":"10.1128\/JVI.73.10.8415-8426.1999","article-title":"Activation of cJUN N-terminal kinase by herpes simplex virus type 1 enhances viral replication","volume":"73","author":"McLean","year":"1999","journal-title":"J. Virol."},{"key":"10.1016\/j.molmed.2005.03.005_bib17","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1038\/sj.cdd.4400572","article-title":"Activation of the JNK pathway is important for cardiomyocyte death in response to simulated ischaemia","volume":"6","author":"He","year":"1999","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.molmed.2005.03.005_bib18","doi-asserted-by":"crossref","first-page":"4531","DOI":"10.1074\/jbc.C000815200","article-title":"Inhibition of JNK by overexpression of the JNK binding domain of JIP-1 prevents apoptosis in sympathetic neurons","volume":"276","author":"Harding","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2005.03.005_bib19","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1046\/j.1471-4159.2001.00150.x","article-title":"Direct inhibition of c-Jun N-terminal kinase in sympathetic neurones prevents c-jun promoter activation and NGF withdrawal-induced death","volume":"76","author":"Eilers","year":"2001","journal-title":"J. Neurochem."},{"key":"10.1016\/j.molmed.2005.03.005_bib20","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1042\/0264-6021:3580489","article-title":"c-Jun N-terminal kinase-interacting protein 1 inhibits gene expression in response to hypertrophic agonists in neonatal rat ventricular myocytes","volume":"358","author":"Finn","year":"2001","journal-title":"Biochem. J."},{"key":"10.1016\/j.molmed.2005.03.005_bib21","doi-asserted-by":"crossref","first-page":"10433","DOI":"10.1073\/pnas.181182298","article-title":"Gene transfer of the JNK interacting protein-1 protects dopaminergic neurons in the MPTP model of Parkinson's disease","volume":"98","author":"Xia","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molmed.2005.03.005_bib22","doi-asserted-by":"crossref","first-page":"10987","DOI":"10.1074\/jbc.M107565200","article-title":"Identification of the critical features of a small peptide inhibitor of JNK activity","volume":"277","author":"Barr","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2005.03.005_bib23","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0898-6568(02)00112-2","article-title":"Molecular recognitions in the MAP kinase cascades","volume":"15","author":"Tanoue","year":"2003","journal-title":"Cell. Signal."},{"key":"10.1016\/j.molmed.2005.03.005_bib24","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1038\/nm911","article-title":"A peptide inhibitor of c-Jun N-terminal kinase protects against excitotoxicity and cerebral ischemia","volume":"9","author":"Borsello","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.molmed.2005.03.005_bib25","doi-asserted-by":"crossref","first-page":"36327","DOI":"10.1074\/jbc.M402181200","article-title":"The critical features and the mechanism of inhibition of a kinase interaction motif-based peptide inhibitor of JNK","volume":"279","author":"Barr","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2005.03.005_bib26","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1038\/sj.emboj.7600212","article-title":"Structural basis for the selective inhibition of JNK1 by the scaffolding protein JIP1 and SP600125","volume":"23","author":"Heo","year":"2004","journal-title":"EMBO J."},{"key":"10.1016\/j.molmed.2005.03.005_bib27","doi-asserted-by":"crossref","first-page":"43178","DOI":"10.1074\/jbc.M405900200","article-title":"Reverse two-hybrid screening identifies residues of JNK required for interaction with the kinase interaction motif of JNK-interacting protein-1","volume":"279","author":"Barr","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2005.03.005_bib28","doi-asserted-by":"crossref","first-page":"11843","DOI":"10.1074\/jbc.M311841200","article-title":"Docking interactions in the c-Jun N-terminal pathway","volume":"279","author":"Mooney","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2005.03.005_bib29","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1038\/nm996","article-title":"Transducible TAT\u2013HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosis","volume":"10","author":"Wadia","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.molmed.2005.03.005_bib30","doi-asserted-by":"crossref","first-page":"77","DOI":"10.2337\/diabetes.50.1.77","article-title":"Cell-permeable inhibitors of JNK: novel blockers of \u03b2-cell death","volume":"50","author":"Bonny","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/j.molmed.2005.03.005_bib31","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.2337\/diabetes.49.9.1468","article-title":"The c-Jun amino-terminal kinase pathway is preferentially activated by interleukin-1 and controls apoptosis in differentiating pancreatic \u03b2-cells","volume":"49","author":"Ammendrup","year":"2000","journal-title":"Diabetes"},{"key":"10.1016\/j.molmed.2005.03.005_bib32","doi-asserted-by":"crossref","first-page":"339","DOI":"10.2174\/1389203033487054","article-title":"The design, synthesis and application of stereochemical and directional peptide isomers: a critical review","volume":"4","author":"Fischer","year":"2003","journal-title":"Curr. Protein Pept. Sci."},{"key":"10.1016\/j.molmed.2005.03.005_bib33","doi-asserted-by":"crossref","first-page":"18368","DOI":"10.1074\/jbc.M300102200","article-title":"Insulin-secreting \u03b2-cell dysfunction induced by human lipoproteins","volume":"278","author":"Roehrich","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2005.03.005_bib34","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S1043-4666(03)00242-4","article-title":"The JNK binding domain of islet-brain 1 inhibits IL-1 induced JNK activity and apoptosis but not the transcription of key proapoptotic or protective genes in insulin-secreting cell lines","volume":"24","author":"Nikulina","year":"2003","journal-title":"Cytokine"},{"key":"10.1016\/j.molmed.2005.03.005_bib35","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1038\/nm1111","article-title":"Possible novel therapy for diabetes with cell-permeable JNK-inhibitory peptide","volume":"10","author":"Kaneto","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.molmed.2005.03.005_bib36","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1126\/science.285.5433.1569","article-title":"In vivo protein transduction delivery of a biologically important protein into the mouse","volume":"285","author":"Schwarze","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.molmed.2005.03.005_bib37","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1126\/science.288.5467.870","article-title":"Requirement of JNK for stress-induced activation of the cytochrome c-mediated death pathway","volume":"288","author":"Tournier","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.molmed.2005.03.005_bib38","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1038\/39899","article-title":"Absence of excitotoxicity induced apoptosis in the hippocampus of mice lacking the Jnk3 gene","volume":"389","author":"Yang","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2005.03.005_bib39","doi-asserted-by":"crossref","first-page":"15184","DOI":"10.1073\/pnas.2336254100","article-title":"A critical role of neural-specific JNK3 for ischemic apoptosis","volume":"100","author":"Kuan","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molmed.2005.03.005_bib40","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/S0140-6736(03)14544-8","article-title":"Stroke","volume":"362","author":"Warlow","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.molmed.2005.03.005_bib41","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.neulet.2004.02.009","article-title":"Protection against malonate-induced ischemic brain injury in rat by a cell-permeable peptidic c-Jun N-terminal kinase inhibitor, (L)-HIV-TAT48-57-PP-JBD20, observed by the apparent diffusion coefficient mapping magnetic resonance imaging method","volume":"359","author":"Asanuma","year":"2004","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.molmed.2005.03.005_bib42","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1161\/01.STR.0000131480.03994.b1","article-title":"D-JNKI1, a cell-penetrating c-Jun-N-terminal kinase inhibitor, protects against cell death in severe cerebral ischemia","volume":"35","author":"Hirt","year":"2004","journal-title":"Stroke"},{"key":"10.1016\/j.molmed.2005.03.005_bib43","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.brainres.2003.10.029","article-title":"Role of tumor necrosis factor receptor-1 in the death of retinal ganglion cells following optic nerve crush injury in mice","volume":"996","author":"Tezel","year":"2004","journal-title":"Brain Res."},{"key":"10.1016\/j.molmed.2005.03.005_bib44","doi-asserted-by":"crossref","first-page":"27971","DOI":"10.1074\/jbc.M302530200","article-title":"Activation of the c-Jun N-terminal kinase signaling cascade mediates the effect of amyloid-\u03b2 on long term potentiation and cell death in hippocampus: a role for interleukin-1\u03b2?","volume":"278","author":"Minogue","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2005.03.005_bib45","doi-asserted-by":"crossref","first-page":"3370","DOI":"10.1523\/JNEUROSCI.1633-03.2004","article-title":"Block of long-term potentiation by naturally secreted and synthetic amyloid \u03b2-peptide in hippocampal slices is mediated via activation of the kinases c-Jun N-terminal kinase, cyclin-dependent kinase 5, and p38 mitogen-activated protein kinase as well as metabotropic glutamate receptor type 5","volume":"24","author":"Wang","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.molmed.2005.03.005_bib46","doi-asserted-by":"crossref","first-page":"8596","DOI":"10.1523\/JNEUROSCI.23-24-08596.2003","article-title":"A peptide inhibitor of c-Jun N-terminal kinase protects against both aminoglycoside and acoustic trauma-induced auditory hair cell death and hearing loss","volume":"23","author":"Wang","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.molmed.2005.03.005_bib47","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/S1367-5931(02)00385-X","article-title":"Mimicry of bioactive peptides via non-natural, sequence-specific peptidomimetic oligomers","volume":"6","author":"Patch","year":"2002","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.molmed.2005.03.005_bib48","doi-asserted-by":"crossref","first-page":"57","DOI":"10.2174\/1568011033353506","article-title":"Peptidomimetic design of CDK inhibitors targeting the recruitment site of the cyclin subunit","volume":"3","author":"McInnes","year":"2003","journal-title":"Curr. Med. Chem. Anti-Canc. Agents"},{"key":"10.1016\/j.molmed.2005.03.005_bib49","doi-asserted-by":"crossref","first-page":"3693","DOI":"10.1016\/j.bmcl.2003.08.014","article-title":"Identification of novel inhibitors of BCR\u2013ABL tyrosine kinase via virtual screening","volume":"13","author":"Peng","year":"2003","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.molmed.2005.03.005_bib50","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1021\/jm030827e","article-title":"Discovery of a potent and selective protein kinase CK2 inhibitor by high-throughput docking","volume":"46","author":"Vangrevelinghe","year":"2003","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.molmed.2005.03.005_bib51","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.2174\/0929867043365062","article-title":"The design of drug candidate molecules as selective inhibitors of therapeutically relevant protein kinases","volume":"11","author":"Fischer","year":"2004","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.molmed.2005.03.005_bib52","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/S0896-6273(00)80727-8","article-title":"The Jnk1 and Jnk2 protein kinases are required for regional specific apoptosis during early brain development","volume":"22","author":"Kuan","year":"1999","journal-title":"Neuron"},{"key":"10.1016\/j.molmed.2005.03.005_bib53","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.molcel.2004.06.007","article-title":"JNK regulates autocrine expression of TGF-\u03b21","volume":"15","author":"Ventura","year":"2004","journal-title":"Mol. Cell"},{"key":"10.1016\/j.molmed.2005.03.005_bib54","doi-asserted-by":"crossref","first-page":"14114","DOI":"10.1073\/pnas.0406061101","article-title":"The c-Jun NH2-terminal kinase is essential for epidermal growth factor expression during epidermal morphogenesis","volume":"101","author":"Weston","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molmed.2005.03.005_bib55","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1126\/science.1101909","article-title":"Requirement of JNK2 for scavenger receptor A-mediated foam cell formation in atherogenesis","volume":"306","author":"Ricci","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.molmed.2005.03.005_bib56","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1002\/art.10104","article-title":"Joint damage and inflammation in c-Jun N-terminal kinase 2 knockout mice with passive murine collagen-induced arthritis","volume":"46","author":"Han","year":"2002","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.molmed.2005.03.005_bib57","doi-asserted-by":"crossref","first-page":"4317","DOI":"10.1242\/jcs.00082","article-title":"JNK1 modulates osteoclastogenesis through both c-Jun phosphorylation dependent and independent mechanisms","volume":"115","author":"David","year":"2002","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.molmed.2005.03.005_bib58","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/nature01137","article-title":"A central role for JNK in obesity and insulin resistance","volume":"420","author":"Hirosumi","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2005.03.005_bib59","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/S1359-6446(04)03251-9","article-title":"Targeting JNK3 for the treatment of neurodegenerative disorders","volume":"9","author":"Resnick","year":"2004","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.molmed.2005.03.005_bib60","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1073\/pnas.0307453101","article-title":"JNK-mediated induction of cyclooxygenase 2 is required for neurodegeneration in a mouse model of Parkinson's disease","volume":"101","author":"Hunot","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molmed.2005.03.005_bib61","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0092-8674(02)00741-9","article-title":"The conformational plasticity of protein kinases","volume":"109","author":"Huse","year":"2002","journal-title":"Cell"},{"key":"10.1016\/j.molmed.2005.03.005_bib62","first-page":"617","article-title":"Design strategies for protein kinase inhibitors","volume":"7","author":"Parang","year":"2004","journal-title":"Curr. Opin. Drug Discov. Devel."},{"key":"10.1016\/j.molmed.2005.03.005_bib63","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1126\/science.1095920","article-title":"Protein kinase inhibitors: insights into drug design from structure","volume":"303","author":"Noble","year":"2004","journal-title":"Science"}],"container-title":["Trends in Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471491405000742?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471491405000742?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,7,8]],"date-time":"2021-07-08T18:11:45Z","timestamp":1625767905000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471491405000742"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,5]]},"references-count":63,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2005,5]]}},"alternative-id":["S1471491405000742"],"URL":"https:\/\/doi.org\/10.1016\/j.molmed.2005.03.005","relation":{},"ISSN":["1471-4914"],"issn-type":[{"value":"1471-4914","type":"print"}],"subject":[],"published":{"date-parts":[[2005,5]]}}}